This article is more than 5 years old. Information may no longer be current.
Cayenne Medical Inc. launches CrossFix II Meniscal Repair System
Click Here to Manage Email Alerts
Cayenne Medical Inc. has announced in a press release the launch of its CrossFix II Meniscal Repair System, a second generation device for treatment of traumatic meniscal tears.
According to a company press release, the CrossFix II platform features a minimally invasive, all-suture meniscal repair that reportedly reduces the risk of chondral injury associated with other implantable meniscal devices. Its “all-inside” technique uses suture delivery needles, available in both curved and straight designs, inserted through a single incision to gain access to multiple tear sites from the inside surface of the meniscus. The procedure replicates the repair of standard, open suturing techniques.
“Evolving our already best-in-class meniscal repair technology to further enhance performance and cater to specific surgeon needs represents Cayenne Medical’s commitment to providing innovative solutions for the sports medicine market,” David Springer, CEO of Cayenne Medical, stated in a company release.“We fully expect CrossFix II to be as well received as our second generation soft tissue knee ligament reconstruction device, AperFix II, launched only a few months ago.”